0001679593-16-000001.txt : 20160720 0001679593-16-000001.hdr.sgml : 20160720 20160720165209 ACCESSION NUMBER: 0001679593-16-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20160720 DATE AS OF CHANGE: 20160720 EFFECTIVENESS DATE: 20160720 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Synapsin Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001679593 IRS NUMBER: 060329603 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-267417 FILM NUMBER: 161775917 BUSINESS ADDRESS: STREET 1: 1225 LAUREL STREET STREET 2: SUITE 213 CITY: COLUMBIA STATE: SC ZIP: 29201 BUSINESS PHONE: 8035450075 MAIL ADDRESS: STREET 1: 1225 LAUREL STREET STREET 2: SUITE 213 CITY: COLUMBIA STATE: SC ZIP: 29201 D 1 primary_doc.xml X0707 D LIVE 0001679593 Synapsin Pharmaceuticals, Inc. 1225 LAUREL STREET SUITE 213 COLUMBIA SC SOUTH CAROLINA 29201 8035450075 DELAWARE None None Corporation true John Dorsey Denis 1225 LAUREL STREET SUITE 213 COLUMBIA SC SOUTH CAROLINA 29210 Executive Officer Director MARK KINDY 5116 Cypress Palms Lane TAMPA FL FLORIDA 33647 Executive Officer Director Pharmaceuticals No Revenues 06b false 2016-07-05 false true false 50000 3750000 375000 3375000 false 1 0 0 120000 true Based upon proposed consultation agreements that are not signed as of the date of this application. false Synapsin Pharmaceuticals, Inc. /Denis Dorsey/ Denis Dorsey President 2016-07-20